Tuesday’s analyst upgrades and downgrades

Analyst actions were mixed across Canadian industrials, insurers, and logistics names, with several target hikes but also a downgrade of Trican Well Service to sector perform from outperform amid softer fracturing pricing and a new natural-gas engine upgrade cycle. Key calls included higher targets for Celestica to US$425, TFI International to $190, and Trisura to $60, while GFL was downgraded by Goldman and JPMorgan on deal-related concerns. The notes also highlighted slower buybacks at Trican, cautious but positive views on P&C insurers, and expectations for mixed Q1 results across multiple sectors.

Analysis

The clearest second-order effect is that the Canadian services complex is shifting from a “scarcity rent” phase into a competitive capex cycle, which compresses margins even before activity rolls over. That matters most for names whose equity story was built on buyback-driven per-share growth: once fleet investment rises, buybacks become the marginal shock absorber and multiple support weakens. In that setup, the market should differentiate between operators with genuine cross-border pricing power and those simply riding a cyclical upgrade wave.

In pressure pumping, the near-term winner is likely the supplier mix rather than the fleet owners. If natural-gas engine upgrades proliferate, engine OEMs, parts, and maintenance ecosystems capture a larger share of the incremental economics while the service providers carry the depreciation burden and face more commoditized pricing. Trican’s setup is especially vulnerable because the valuation still embeds premium execution, but the forward FCF path is now moving against the stock just as estimate revisions become the dominant driver.

By contrast, the strongest relative opportunities sit where pricing is improving faster than capex inflation or where earnings visibility is being pulled forward. Celestica and TFI both fit that profile: one is benefiting from demand pull-through and better supply visibility, the other from capacity rationalization that can lag operating weakness but still reprice revenue units. In insurance, the market is underestimating how much buybacks and lower share counts can offset a middling macro, but the upside is more about multiple durability than explosive earnings acceleration. The main contrarian risk is that investors chase the most cyclical laggards into the quarter, only to find that “better pricing” is already fully offset by tougher comps, higher equipment costs, and slower capital returns.

Key Decisions for Investors

• Short TCW.TO on strength into earnings or a post-report rally; downside is driven by falling FCF conversion and lower buyback support, with the thesis working over 1-2 quarters if pricing stays soft.
• Long CLS vs short TFII as a relative-value pair over the next 1-3 months: both have positive revisions, but CLS has the cleaner demand visibility and more credible multiple expansion runway.
• Buy CEU.TO on pullbacks as the higher-quality beneficiary of North American services activity; it has better leverage to activity without the same fleet-capex drag as pressure pumping names.
• Own TSU.TO versus DFY.TO for the next quarter: TSU’s growth mix and capital return profile look more self-help driven, while DFY carries more execution risk from acquisition integration.
• Consider selling upside calls on CFW.TO or ESI.TO rather than outright long exposure; these names look like lower-conviction laggards where a modest target raise may not translate into meaningful multiple re-rating.